Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
$179.00 USD
Updated Sep 20 12:43pm
Add VRTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
VRTX Stock Chart More Charts
VRTX Price/Volume Stats
| Current price | $179.00 |
| Prev. close | $176.14 |
| Day low | $175.58 |
| Day high | $179.55 |
| 50-day MA | $177.29 |
| 200-day MA | $177.91 |
| 52-week high | $195.81 |
| 52-week low | $151.80 |
| Volume | 736,285 |
| Avg. volume | 1,283,095 |
| Dividend yield | N/A |
| Market Cap | 46.01B |
Vertex Pharmaceuticals Incorporated (VRTX) Company Bio
Vertex Pharmaceuticals engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs. The company was founded in 1989 and is based in Boston, Massachusetts.
Top Stories View All
What's next for Canopy Growth (CGC), as Bruce Linton finally moves on
What Quadruple Witching Friday Means for Investors
Best & Worst Performing Stock Industries for September 19, 2019
Best & Worst Performing Small Cap Stocks for September 19, 2019
Best & Worst Performing Mid Cap Stocks for September 19, 2019
View All Top Stories
Loading social stream, please wait...